Mammalian Interphase Cdks: Dispensable Master Regulators of the Cell Cycle
Open Access
- 1 November 2012
- journal article
- Published by SAGE Publications in Genes & Cancer
- Vol. 3 (11-12), 614-618
- https://doi.org/10.1177/1947601913479799
Abstract
Cyclin-dependent kinases (Cdks) drive cell cycle progression in all eukaryotes. Yeasts have a single major Cdk that mediates distinct cell cycle transitions via association with different cyclins. The closest homolog in mammals, Cdk1, drives mitosis. Mammals have additional Cdks—Cdk2, Cdk4, and Cdk6—that represent the major Cdks activated during interphase (iCdks). A large body of evidence has accrued that suggests that activation of iCdks dictates progression though interphase. In apparent contradiction, deficiency in each individual iCdk, respectively, in knockout mice proved to be compatible with live birth and in some instances fertility. Moreover, murine embryos could be derived with Cdk1 as the only functional Cdk. Thus, none of the iCdks is strictly essential for mammalian cell cycle progression, raising the possibility that Cdk1 is the dominant regulator in interphase. However, an absence of iCdks has been accompanied by major shifts in cyclin association to Cdk1, suggesting gain in function. After considerable tweaking, a chemical genetic approach has recently been able to examine the impact of acute inhibition of Cdk2 activity without marked distortion of cyclin/Cdk complex formation. The results suggest that, when expressed at its normal levels, Cdk2 performs essential roles in driving human cells into S phase and maintaining genomic stability. These new findings appear to have restored order to the cell cycle field, bringing it full circle to the view that iCdks indeed play important roles. They also underscore the caveat in knockdown and knockout approaches that protein underexpression can significantly perturb a protein interaction network. We discuss the implications of the new synthesis for future cell cycle studies and anti–Cdk-based therapy of cancer and other diseases.Keywords
This publication has 80 references indexed in Scilit:
- Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human CellsPLoS Genetics, 2012
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancersNature, 2011
- Requirements for Cdk7 in the Assembly of Cdk1/Cyclin B and Activation of Cdk2 Revealed by Chemical Genetics in Human CellsMolecular Cell, 2007
- Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage ResponseCancer Research, 2005
- Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinomaGenes & Development, 2003
- Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entryGenes & Development, 1998
- Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1The EMBO Journal, 1997
- Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection ofcyclin D1 in breast andcyclin E in ovarian tumorsInternational Journal of Cancer, 1996
- Regulation of retinoblastoma protein functions by ectopic expression of human cyclinsCell, 1992
- Functionally homologous cell cycle control genes in budding and fission yeastNature, 1982